4-121332987-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_198179.3(QRFPR):ā€‹c.631C>Gā€‹(p.Gln211Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000312 in 1,581,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00032 ( 0 hom., cov: 31)
Exomes š‘“: 0.00031 ( 0 hom. )

Consequence

QRFPR
NM_198179.3 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.27
Variant links:
Genes affected
QRFPR (HGNC:15565): (pyroglutamylated RFamide peptide receptor) Enables G protein-coupled receptor activity. Involved in G protein-coupled receptor signaling pathway. Predicted to be located in non-motile cilium. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06750369).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
QRFPRNM_198179.3 linkuse as main transcriptc.631C>G p.Gln211Glu missense_variant 4/6 ENST00000394427.3 NP_937822.2 Q96P65

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
QRFPRENST00000394427.3 linkuse as main transcriptc.631C>G p.Gln211Glu missense_variant 4/61 NM_198179.3 ENSP00000377948.2 Q96P65
QRFPRENST00000334383.9 linkuse as main transcriptc.631C>G p.Gln211Glu missense_variant 4/62 ENSP00000335610.5 J3KNR3
QRFPRENST00000507331.5 linkuse as main transcriptn.*189C>G non_coding_transcript_exon_variant 5/72 ENSP00000423369.1 F2Z3L3
QRFPRENST00000507331.5 linkuse as main transcriptn.*189C>G 3_prime_UTR_variant 5/72 ENSP00000423369.1 F2Z3L3

Frequencies

GnomAD3 genomes
AF:
0.000322
AC:
39
AN:
121086
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000496
Gnomad ASJ
AF:
0.000723
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000443
Gnomad OTH
AF:
0.00190
GnomAD3 exomes
AF:
0.000398
AC:
100
AN:
251250
Hom.:
0
AF XY:
0.000427
AC XY:
58
AN XY:
135772
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000502
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000311
AC:
454
AN:
1460788
Hom.:
0
Cov.:
32
AF XY:
0.000325
AC XY:
236
AN XY:
726644
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000560
Gnomad4 ASJ exome
AF:
0.000919
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000697
Gnomad4 FIN exome
AF:
0.000112
Gnomad4 NFE exome
AF:
0.000324
Gnomad4 OTH exome
AF:
0.000381
GnomAD4 genome
AF:
0.000322
AC:
39
AN:
121206
Hom.:
0
Cov.:
31
AF XY:
0.000233
AC XY:
14
AN XY:
60064
show subpopulations
Gnomad4 AFR
AF:
0.000123
Gnomad4 AMR
AF:
0.000495
Gnomad4 ASJ
AF:
0.000723
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000443
Gnomad4 OTH
AF:
0.00187
Alfa
AF:
0.000463
Hom.:
0
Bravo
AF:
0.000378
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000445
AC:
54
EpiCase
AF:
0.000655
EpiControl
AF:
0.000830

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 27, 2024The c.631C>G (p.Q211E) alteration is located in exon 4 (coding exon 4) of the QRFPR gene. This alteration results from a C to G substitution at nucleotide position 631, causing the glutamine (Q) at amino acid position 211 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.032
.;T
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.81
T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.068
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.50
.;N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.82
N;N
REVEL
Benign
0.17
Sift
Benign
0.25
T;D
Sift4G
Uncertain
0.032
D;T
Polyphen
0.39
.;B
Vest4
0.34
MVP
0.64
MPC
0.029
ClinPred
0.035
T
GERP RS
6.1
Varity_R
0.57
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139685422; hg19: chr4-122254142; API